Drugs looking for diseases: innovative drug research and the development of the beta blockers and the calcium antagonistsVOS, Rein; FLECKENSTEIN, A.Developments in cardiovascular medicine. 1991, Vol 120, issn 0166-9842, 403 p.Serial Issue

Judging without criteria? Sickness certification in Dutch disability schemesMEERSHOEK, Agnes; KRUMEICH, Anja; VOS, Rein et al.Sociology of health & illness (Print). 2007, Vol 29, Num 4, pp 497-514, issn 0141-9889, 18 p.Article

Extracting the lowest-frequency words : Pitfalls and possibilities = Extraction des mots les moins fréquents : pièges et possibilitésWEEBER, Marc; VOS, Rein; BAAYEN, R. Harald et al.Computational linguistics - Association for Computational Linguistics (Print). 2000, Vol 26, Num 3, pp 301-317, issn 0891-2017Article

The construction of ethnic differences in work incapacity risks: Analysing ordering practices of physicians in the NetherlandsMEERSHOEK, Agnes; KRUMEICH, Anja; VOS, Rein et al.Social science & medicine (1982). 2011, Vol 72, Num 1, pp 15-22, issn 0277-9536, 8 p.Article

Side effects of problem-solving strategies in large-scale nutrition science: towards a diversification of healthPENDERS, Bart; VOS, Rein; HORSTMAN, Klasien et al.British journal of nutrition. 2009, Vol 102, Num 10, pp 1400-1403, issn 0007-1145, 4 p.Article

A question of style: method, integrity and the meaning of proper science = Méthode, intégrité et signification de la science exactePENDERS, Bart; VOS, Rein; HORSTMAN, Klasien et al.Endeavour (English ed.). 2009, Vol 33, Num 3, pp 93-98, issn 0160-9327, 6 p.Article

Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care accessWARDEN, Erik; VAN HOYWEGHEN, Ine; VOS, Rein et al.Human reproduction (Oxford. Print). 2009, Vol 24, Num 7, pp 1542-1547, issn 0268-1161, 6 p.Article

In an exploratory prospective study on multimorbidity general and disease-related susceptibility could be distinguishedVAN DEN AKKER, Marjan; VOS, Rein; KNOTTNERUS, J. André et al.Journal of clinical epidemiology. 2006, Vol 59, Num 9, pp 934-939, issn 0895-4356, 6 p.Article

Assessment of new cardiovascular drugs: Relationships between considerations, professional characteristics, and prescribingWIERINGA, Nicolien F; DENIG, Petra; DE GRAEFF, Pieter A et al.International journal of technology assessment in health care. 2001, Vol 17, Num 4, pp 559-570, issn 0266-4623Article

Connecting pre-marketing clinical research and medical practice opinion-based study of core issues and possible changes in drug regulationWIERINGA, Nicolien F; PESCHAR, Jules L; DENIG, Petra et al.International journal of technology assessment in health care. 2003, Vol 19, Num 1, pp 202-219, issn 0266-4623, 18 p.Article

Using concepts in literature-based discovery : Simulating Swanson's Raynaud-fish oil and migraine-magnesium discoveriesWEEBER, Marc; KLEIN, Henny; DE JONG-VAN DEN BERG, Lolkie T. W et al.Journal of the American Society for Information Science and Technology (Print). 2001, Vol 52, Num 7, pp 548-557, issn 1532-2882Article

Inclusion of patients with comorbidity and comedication in premarketing trials of cardiovascular drugsWIERINGA, Nicolien F; VOS, Rein; VAN DER WERF, Ger Th et al.Drug development research. 2000, Vol 51, Num 3, pp 159-168, issn 0272-4391Article